Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial

Jannik Rousel, Menthe E. Bergmans, Laura W.J. van der Meulen, Lisa Pagan, Digna T. de Bruin, Marieke L. de Kam, Naomi B. Klarenbeek, Joke A. Bouwstra, Marieke M.B. Seyger, Juul M.P.A. van den Reek, Tessa Niemeyer-van der Kolk, NGID consortium, Robert Rissmann*, Martijn B.A. van Doorn

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)395-397
Number of pages3
JournalJournal of the American Academy of Dermatology
Volume90
Issue number2
Early online date5 Oct 2023
DOIs
Publication statusPublished - Feb 2024

Cite this